✦ LIBER ✦

Efficacy and Safety of a Once-Daily Morphine Formulation in Chronic, Moderate-to-Severe Osteoarthritis Pain: Results from a Randomized, Placebo-Controlled, Double-Blind Trial and an Open-Label Extension Trial

✍ Scribed by Jacques R. Caldwell; Ronald J. Rapoport; Jeffrey C. Davis; Howard L. Offenberg; Howard W. Marker; Sanford H. Roth; William Yuan; Lise Eliot; Najib Babul; Pia Mikkelsen Lynch

Book ID: 114266441
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 306 KB
Volume: 23
Category: Article
ISSN: 0885-3924
DOI: 10.1016/s0885-3924(02)00383-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of desloratadine 5 m

Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial*

✍ Eugene Monroe; Albert Finn; Piyush Patel; Robinson Guerrero; Paul Ratner; David 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 121 KB

(248) Analgesic efficacy and safety of c

(248) Analgesic efficacy and safety of controlled-release hydrocodone and acetaminophen tablets, dosed twice daily, for moderate to severe mechanical chronic low-back pain: A randomized, double-blind, placebo-controlled withdrawal trial

✍ C. Codding; D. Levinsky; M. Hale; J. Thomas; E. Lockhart; R. Jain 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Efficacy and Safety of Once-Daily Dosing

Efficacy and Safety of Once-Daily Dosing of Udenafil in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

✍ Chen Zhao; Sae Woong Kim; Dae Yul Yang; Je Jong Kim; Nam Cheol Park; Sung Won Le 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 985 KB

Results of a Double-blind, Placebo-contr

Results of a Double-blind, Placebo-controlled, Fixed-dose Assessment of Once-daily OROS® Hydromorphone ER in Patients with Moderate to Severe Pain Associated with Chronic Osteoarthritis

✍ Richard Rauck; Ronald Rapoport; John Thipphawong 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB

P1-383 Cerebrolysin-efficacy and safety

P1-383 Cerebrolysin-efficacy and safety in moderate to moderately severe Alzheimer's disease: subgroup analysis of a randomized, double-blind, placebo-controlled trial

✍ Herbert Moessler; Antòn X. Álvarez; Ramón Cacabelos 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Efficacy and safety of topical WBI-1001

Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial

✍ R. Bissonnette; C. Bolduc; C. Maari; S. Nigen; J.M. Webster; L. Tang; M. Lyle 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB